GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vicore Pharma Holding AB American Depositary Shares VCRE · USD

US listing · 🇺🇸 United States

Compare

11.27

+8.37%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Vicore Pharma Holding AB American Depositary Shares — daily VCRE Delayed
Market value
$3.17bn
Last close × shares
Volume
8.4k
Shares, 9 Nov 2026

About Vicore Pharma Holding AB American Depositary Shares

Its shares trade under the ticker VCRE. It has been listed since 6 July 2026. In the fiscal year to 31 December 2025, it reported revenue of $398,765 and a net loss of $49.9m. At that date it held total assets of $127.3m and shareholders' equity of $114.4m.

Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company develops Buloxibutid (C21), an orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) that is in Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF), as well as in Phase I clinical trial for treating pulmonary hypertension. It also developing Almee, an investigational medical device in clinical development that has completed Phase III clinical stage to address the psychological impact of living with pulmonary fibrosis. It has a cooperation and development agreement with Emeriti Bio AB and HaLaCore Pharma AB to develop new follow-on molecules based on C21 and other drug substances targeting the AT2 receptor, as well as a collaboration and development agreement with Alex Therapeutics AB to develop a digital app in interstitial lung diseases, such as IPF. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Stockholm, Sweden.

Figures and description from our data supplier, not checked against the company's own report.

More about Vicore Pharma Holding AB American Depositary Shares →

Latest on Vicore Pharma Holding AB American Depositary Shares

Our reporting

We have not reported on Vicore Pharma Holding AB American Depositary Shares yet.

Other United States listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Vicore Pharma Holding AB American Depositary Shares's ticker?

Vicore Pharma Holding AB American Depositary Shares trades as VCRE on its US listing, under ISIN US92581R1041.

What was Vicore Pharma Holding AB American Depositary Shares's last closing price?

11.27 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.